Senior Health link

Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices – United States, 2023

June 23, 2025 5:24 am Published by Comments Off on Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices – United States, 2023
This report describes ACIP’s 2023 recommendation for JYNNEOS vaccine use in people 18 years and older who are at risk for mpox during an mpox outbreak.

Learn More


Categorised in:

This post was written by senioradmin

Comments are closed here.

Chat Icon